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Rapport de synthèse 
Localisation cellulaire des AQP1, AQP4 et AQP9 dans le 
cerveau primate non-humain 
La présence de trois canaux d'eau, appelés aquaporines AQP1, AQP4 et AQP9, 
a été observée dans le cerveau sain ainsi que dans plusieurs modèles des 
pathologies cérébrales des rongeurs. Peu est connu sur la distribution des AQP 
dans le cerveau des primates. Cette connaissance sera utile pour des futurs 
essaies médicamenteux qui visent à prévenir la formation des œdèmes 
cérébraux. 
Nous avons étudié l'expression et la distribution cellulaire des AQP1, 4 et 9 dans 
le cerveau primate non-humain. La distribution des AQP4 dans le cerveau 
primate non-humain a été observée dans des astrocytes périvasculaires, 
comparable à l'observation faite dans le cerveau du rongeur. Contrairement à ce 
qui a été décrit chez le rongeur, l'AQP1 chez le primate est exprimée dans les 
processus et dans les prolongations périvasculaires d'un sous-type d'astrocytes, 
qui est avant tout localisé dans la matière blanche et dans la glia limitans et qui 
est peut-être impliqué dans l'homéostasie de l'eau. L'AQP1 a aussi été observée 
dans les neurones qui innervent des vaisseaux sanguins de la pie-mère, 
suggérant un rôle possible dans la régularisation de la vascularisation cérébrale. 
Comme décrit chez le rongeur, le mRNA et les protéines de l'AQP9 ont été 
détectés dans des astrocytes et dans des neurones catécholaminergiques. Chez 
le primate, des localisations supplémentaires ont été observées dans des 
populations de neurones placées dans certaines zones corticales. 
Cet article décrit une étude détaillée sur la distribution des AQP1, 4 et 9 dans le 
cerveau primate non-humain. Les observations faites s'additionnent aux data 
déjà publié sur le cerveau du rongeur. Ces importantes différences entre les 
espèces doivent être considérées dans l'évaluation des médicaments qui agiront 
potentiellement sur des AQP des primates non-humains avant d'entrer dans la 
phase des essais cliniques sur des humains. 
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Abstract-The presence ofthree water channels (aquaporins, 
AQP), AQP1, AQP4 and AQP9 were observed in normal brain 
and several rodent models of brain pathologies. Little is 
known about AQP distribution in the primate brain and its 
knowledge will be useful for future testing of drugs aimed at 
preventing brain edema formation. We studied the expres-
sion and cellular distribution of AQP1, 4 and 9 in the non-
human primate brain. The distribution of AQP4 in the non-
human primate brain was observed in perivascular astro-
cytes, comparable to the observation made in the rodent 
brain. ln contrast with rodent, primate AQP1 is expressed in 
the processes and perivascular endfeet of a subtype of as-
trocytes mainly located in the white matter and the glia limi-
tans, possibly involved in water homeostasis. AQP1 was also 
observed in neurons innervating the pial blood vessels, sug-
gesting a possible role in cerebral blood flow regulation. As 
described in rodent, AQP9 mRNA and protein were detected 
in astrocytes and in catecholaminergic neurons. However 
additional locations were observed for AQP9 in populations 
of neurons located in several cortical areas of primate brains. 
This report describes a detailed study of AQP1, 4 and 9 
distributions in the non-human primate brain, which adds to 
the data already published in rodent brains. This relevant 
species differences have to be considered carefully to assess 
potential drugs acting on AQPs non-human primate models 
before entering human clinical trials.© 2010 IBRO. Published 
by Elsevier Ltd. Ali rights reserved. 
Key words: aquaporins, astrocyte, water homeostasis, brain 
edema, energy metabolism. 
Aquaporins (AQPs) are a family of water channel pro-
teins ubiquitously distributed in the living world (Amiry-
Moghaddam and Ottersen, 2003). To date, eight aqua-
porins are found to be expressed in the rodent brain: AQP1, 
AQP3, AQP4, AQP5, AQP6, AQP8, AQP9 and AQP11, but 
only AQP1, AQP4 and AQP9 have been clearly identified in 
brain cells in vivo (Badaut et al .. 2007). 
*Correspondance to: J. Badaut, Department of Pediatrics, Loma Linda 
University School of Medicine, Loma Linda, CA 92350, USA. Tel: 
+ 1-909-558-8242; fax: + 1-909-558-04 79. 
E-mail address: jbadaut@llu.edu (J. Badaut). 
Abbreviations: AQPs, aquaporins; GFAP, glial fibrillary acidic protein; 
NMO, neuromyelitis optica; SCI, spinal cord injury. 
AQP4 was the first AQP reported in rat brain (Jung et 
al., 1994) and was shown to be highly expressed in 
perivascular astrocytic endfeet (Nielsen et al., 1997). lts 
presence in rodent brain was observed around all blood 
vessels of any size, in white and gray matter and in all 
brain structures (Badaut et al., 2000a). lt is the dominant 
water channel localized in astrocyte foot processes, in 
contact with blood vessels and the cerebrospinal fluid-
brain interface (pial and ependymal surfaces) (Badaut et 
al., 2002). Since 1997, AQP4 is the most studied AQP in 
mammalian brains and implicated in the physiopathology 
of brain edema, with a dual function depending on the 
pathological model used (Badaut et al., 2007; Tait et al., 
2008). ln mouse models of cytotoxic edema (water intox-
ication and stroke), AQP4 deletion has been shown to be 
protective by reducing edema formation and improving 
survival (Manley et al., 2000). lt was therefore proposed to 
play a central role in the formation of cytotoxic brain 
edema. ln vasogenic edema, AQP4 plays the opposite role 
where its deletion results in decreased edema clearance 
and further progression of disease (Papadopoulos et al., 
2004). There is now more evidence that AQP4 is involved 
in human CNS pathologies. lndeed, recent reports dem-
onstrate the presence of lgG recognizing AQP4 in the 
serum of patients suffering from neuromyelitis optica 
(NMO), an autoimmune demyelinating disease affecting 
optic nerves and the spinal cord (Lennon et al., 2005). This 
serum lgG autoantibody (lgG-NMO) served as a specific 
marker and was found to bind selectively to the extracel-
lular face of the AQP4 water channel (Lennon et al., 2005). 
Furthermore, increased AQP4 expression was also ob-
served in reactive astrocytes during glial scar formation 
and facilitated astrocyte migration (Saadoun et al., 2005b), 
as well as in other human pathologies such as astrocyto-
mas and adenocarcinomas (Saadoun et al., 2002b); in 
sporadic Creutzfeldt-Jakob disease (sCJD) (lwasaki et al., 
2007; Rodriguez et al., 2006) and in HIV-related dementia 
(St Hîllaire et al., 2005). On the other hand, decreased 
AQP4 expression was found in the cerebellum of subjects 
with autism (Fatemi et al., 2008a) and in animal models of 
autism, where prenatal influenza infection in mice resulted 
in a down regulation of AQP4 expression (Fatemi et al., 
2008b, 2005). 
AQP1 was first described in the choroid plexus of 
rodent and primate brains and thought to be involved in the 
production of cerebrospinal fluid (Oshio et al., 2005). 
AQP 1 is also expressed throughout the body of mamma-
lians in many endothelial cells (Nielsen et al., 1993), but its 
expression is suppressed in the specialized endothelial 
cells of the blood-brain barrier (Dolman et al., 2005). 
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lndeed, the presence of astrocytes inhibits the expression 
of AQP1 in endothelial cells (Dolman et al., 2005). Re-
cently, the dorsal horn of the spinal cord and the trigeminal 
sensory ganglia were identified as new cellular locations 
for AQP1 (Nandasena et al., 2007; Oshio et al., 2006). ln 
these areas, AQP1 may play a role in pain sensation as, 
interestingly, the expression of AQP1 in small diameter 
sensory fibers of the dorsal horn is locally significantly 
increased 10 days after spinal cord injury (SCI), persisting 
up to 11 months post-contusion. AQP1 is proposed to play 
two distinctive roles in the reaction after SCI: (i) at early 
time points post-SCI increase in expression contributes to 
astrocytic reactivity and neuronal swelling and (ii) the de-
layed increase in expression contributes to development of 
chronic neuropathie pain after SCI (Nesic et al., 2008). 
ln human, AQP1 expression was also found to be 
enhanced in reactive astrocytes with highly branched pro-
cesses surrounding blood vessels, along the glial scar and 
accumulating in brain lesions in Alzheimer's disease, 
Creutzfeldt-Jakob disease, multiple sclerosis and in isch-
emic lesions (Misawa et al., 2008; Satoh et al., 2007). 
Under these pathological conditions, AQP1 is suggested to 
play a complementary role to AQP4 in brain water ho-
meostasis (Misawa et al., 2008; Satoh et al., 2007). To 
date, regional and cellular distribution of AQP1 in healthy 
human and non-human primate brain has never been in-
vestigated in detail. 
The aquaglyceroporin, AQP9 has been reported to be 
present in glial cells (Bada ut et al., 2001; Elkjaer et al., 
2000) and in catecholaminergic neurons (Badaut et al., 
2004) in rodent brains. With regards to AQP9 localization 
and its permeability properties, AQP9 was hypothesized to 
play arole in brain energy homeostasis (Badau! and Regli, 
2004). lnterestingly, the level of AQP9 expression is in-
creased in astrocytes after stroke (de Castro Ribeiro et al., 
2006) and in catecholaminergic neurons in a diabetes 
model in rats (Badaut et al., 2008). Despite many publica-
tions which describe the presence of AQP9 in the rodent 
brain (Amiry-Moghaddam et al., 2005; Badaut et al., 2001, 
2004; de Castro Ribeiro et al., 2006; Elkjaer et al., 2000; 
Tsukaguchi et al., 1998), it has now became a matter of 
debate following a recent publication (Rojek et al., 2007), 
suggesting that AQP9 is not expressed in the mouse brain 
and raising the question of its expression in primate brain. 
Most investigations have been carried out in rodent 
brains (mice and rats) and there is no description of AQPs 
in normal primate brains. Cells in the CNS differ between 
rodents and primates, for example: human protoplasmic 
astrocytes manifest a threefold larger diameter and have 
tenfold more primary processes than those of rodents 
(Oberheim el al., 2006). Since AQP1, 4 and 9 are ail found 
in astrocytes (Badaut et al., 2007), it is important to inves-
tigate possible evolutionary differences between rodents 
and primates, in the expression and distribution of AQPs. 
This knowledge will be essential for the development of 
future therapeutic agents targeting AQPs to prevent brain 
edema formation (Tait et al., 2008). Using RT-PCR and 
immunohistochemical approaches, we provide new data 
on the expression and regional, cellular distribution of 
AQP1, AQP4 and AQP9 in the primate brain. 
EXPERIMENTAL PROCEDURES 
Tissue preparation 
The experiments were conducted on sections from three adult 
monkey brains (Macaca fascicularis). The animais were between 
4 and 8.5 years old and weight 2.9-3.5 kg. They lived in group of 
four in a space of 16 m3 . They were fed once a day and had free 
access to water. Animal care was conducted in accordance with 
the NIH Guide for the care and use of /aboratory animais (ISBN 
0-309-05377-3; 1996) and was approved by the local Swiss vet-
erinary authority. 
The animais were killed under deep (lethal) anaesthesia (90 
mg sodium pentobarbital/kg body weight, Sigma-Aldrich, St. 
Louis, MO, USA) by transcardiac perfusion with 0.9% saline (400 
ml). The perfusion was continued with fixative (3 1 of 4% phos-
phate-buffered paraformaldehyde (Sigma-Aldrich, St. Louis, MO, 
USA) in 0.1 M phosphate buffer, pH 7.6) and solutions (2 1 each) 
of the same fixative containing increasing concentrations of su-
crase (10%, 20%, and 30%). The brain was dissected and placed 
in a 30% sucrase in phosphate buffer solution for cryoprotection 
for 7 days. Fifty micrometres thick sections were prepared with a 
cryotome (HM560, MICROM, Volketswil, Switzerland) and were 
stored al -80 °C in cryoprotection solution (50 mM phosphate 
buffer pH 7.4) containing 25% glycerol (G7893, Sigma-Aldrich, St 
Louis, MO, USA) and 30% ethylene glycol (33068, Ridel-de-Haën, 
Seelze, Germany). 
Tissue analysis 
The Macaca fascicularis brains were analyzed by steps of 1 mm 
coronal sections, beginning al -32 mm and pursuing until + 7 mm 
based on the Atlas of the primate brain published from the Wash-
ington University (http://braininfo.rprc.washington.edu/). Most at-
tention was given Io coronal sections between -5 and -13 mm. 
These sections contain cerebral structures that have previously 
been studied in redents and where thus useful to serve as com-
parison in our studies. Cerebellum was not included in our studies. 
Real Time Nested-PCR experiments 
mRNA was extracted from fixed brain slices from the three Ma-
caca fascicularis monkeys adjacent to slices of interest used for 
immunohistochemistry using RNeasy® FFPE extraction kit (Qia-
gen, Hilden, Germany) and following the procedure proposed by 
the company. The quality of the mRNA was assessed using a 
bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). 
cDNAs were generated from 500 ng of total mRNA using Biolabs 
M-MuLV Reverse Transcriptase (200 U/µI) as described by the 
supplier. PCR experiments were performed using the HotStarTaq 
Master Mix Kit from Qiagen using 2 µI of cDNA/5 pmol of primer 
and 35 cycles using a Thermocycler (Biometra, Goettingen Ger-
many) with denaturation (94 °C, 30 s), annealing (48 °c, 45 s for 
AQP1, 4 and 9 and 56 °C, 45 s for Actin) and extension (72 °C, 
80 s). The Nested-PCR reaction (no! used for Actin amplification) 
used 1 µI of the first PCR product with 5 pmol of primer and 
consisted of 30 cycles in the same conditions as for the first PCR 
reactions. Primers used were specific for human AQP1, human 
AQP4, human AQP9 and human Actin and are specified in Table 
1. Specificity of PCR products were controlled by sequence anal-
ysis (data no! shown). 
Single immunolabeling for regional studies 
lmmunolabeling was carried out in PBS containing 0.3% Triton 
X-100 and 0.25% bovine serum albumin on adjacent serial 50-
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Table 1. Gene-specific N-PCR primers and their respective fragment size 
GenBank accession Primer Nucleotide sequence Position Final fragment size 
U41517 
063412 
AB008775 
Human AQP1 Fo1 
Human AQP1 Re1 
Human AQP1 Fo2 
Human AQP1 Re2 
Human AQP4 Fo1 
Human AQP4 Re1 
Human AQP4 Fo2 
Human AQP4 Re2 
Human AQP9 Fo1 
Human AQP9 Re1 
Human AQP9 Fo2 
Human AQP9 Re2 
5'-GTC CAG GAC AAC GTG AAG GT-3' 
5'-CCC TCC ACT GCA CCT CCT GG-3' 
5'-ACC GCG TGA AGG TGT GGA CC-3' 
5'-ACT AGC AGG TGG GTC CCT TT-3' 
5'-TTG CTT TGG ACT CAG CAT TG-3' 
5'-CTG TTG TCC TCC ACC TCC AT-3' 
5'-CTG TCT TCT ACA TCG CAG CCC AG-3' 
5'-GGG ATT CAT GCT GGC ACC AG-3' 
5'-GCC CAA GCT ATT CTC AGT CG-3' 
5'-GCA GAC AAA ACT GGG TGG AT-3' 
5'-GTC CTT TGC TGG TGG AAA ACT GC-3' 
5'-GGC CCA CTA CAG GAA TCC ACC-3' 
169-189 
1306-1325 
752-772 
1104-1124 
245-264 
852-871 
364-386 
643-662 
349-369 
1197-1216 
603-625 
947-967 
372 bp 
298 bp 
364 bp 
Fo, forward; Re, reverse. 
µm-thick coronal free floating sections of Macaca fascicu/aris 
brain. After each incubation, sections were rinsed in PBS 3X10 
min. The sections were first incubated overnight at 4 °C with 
rotation with anti-AQP1 {dilution: 1/200; Chemicon, Temecula, 
CA, USA), anti-AQP4 (dilution: 1/200; Chemicon, Temecula, CA, 
USA) and anti-AQP9 (dilution: 1/200; Alpha Diagnostics, San 
Antonio, TX, USA). After washing, floating sections were then 
incubated for 2 h at room temperature with a biotinylated second-
ary goal anti-rabbit antibody (dilution: 1/200; Vector Laboratories, 
Burlingame, CA, USA). The sections were then rinsed and ex-
posed for 1 h to avidin-biotin complex solution (Vectastain kit; 
Vector Laboratories, Burlingame, CA, USA) before application of 
diaminobenzidine (DAB; Vector kit, Vector Laboratories). Floating 
sections were rinsed, mounted on slides and then coverslipped 
with Eukit Medium. Controls were performed by omitting primary 
antibody. Contrai sections showed no detectable labeling. 
Double immunofluorescence 
Sections were incubated with either one primary antibody (see 
Table 2) or a mixture of Iwo primary antibodies over night al 4 °C 
with rotation and then with either one secondary antibody or a 
mixture of two secondary antibodies: anti-rabbit cou pied to Alexa-
dye 594 nm (dilution: 1/1000, lnvitragen, Switzerland} and anti-
mouse coupled to Alexa-dye 488 nm (dilution: 1/1000, lnvitragen, 
Switzerland} for 2 h at raom temperature. After immunofluores-
cence, sections were mounted and coverslipped with mounting 
medium Vectashield (Vector Laboratories, Burlingame, CA, USA). 
Controls were performed by omitting either one or both primary 
antibodies. Contrai sections showed no detectable labeling. 
Table 2. Antibodies and dilutions used in this study 
Primary antisera 
Anti-AQP1 {Chemicon, rabbi!, 
1/200) 
Anti-AQP4 (Chemicon, rabbi!, 
1/200) 
Anti-AQP9 (Alpha Diagnostics, 
rabbi!, 1/200) 
Anti-GFAP (Sigma, mouse, 1/500) 
Anti-TH (Chemicon, mouse, 1/20) 
Anti-NF 70+200 kDa (Bio-Science 
Products, mouse, 1/100) 
Secondary antisera 
Alexa 594 goal anti-rabbit 
(lnvitrogen, 1/1000) 
Alexa 488 goal anti-mouse 
{lnvitrogen, 1/1000) 
CY3 goal anti-rabbit (Sigma, 
1/1000) 
Alexa 488 goal anti-mouse 
(lnvitrogen, 1/1000) 
FITC goal anti-mouse (Sigma, 
1/1000) 
Alexa 488 goal anti-mouse 
{lnvitrogen, 1/1000) 
Image acquisitions 
The entire section of a single immunostaining was scanned by a 
HP Scanjet 4850 with a resolution of 600 pixels/inch Io obtain a 
single picture of the whole section. 
Single immunolabeling revealed by DAB staining was observed 
and photographed using optical microscopy (Olympus BX40, Swit-
zerland}. lmmunofluorescent preparations were examined using epi-
fluorescence microscopy (Olympus BX 40, Switzerland), equipped 
with a Qimagin, QICAM Fast {1394) camera and ExploraNova Fluo 
30 software (ExploraNova, La Rochelle, France). The epifluores-
cence of FITC, CY3, Alexa 488 and Alexa 594 was successively 
photographed through different filters and then superposed. 
RT-PCR images were acquired with an infrared Scanner {Od-
yssey, fram Licor, Germany) detecting Syto60 and using software 
Odyssey 1.2. 
RESULTS 
Detection of AQP4, 1 and 9 mRNAs in Macaca 
fascicu/aris brain 
The expression of AQP4, 1 and 9 mRNAs was first eval-
uated by RT-PCR using fixed Macaca fascicu/aris brain 
slices, adjacent to the slices used for immunohistochemi-
cal studies. Fragments of the expected size were obtained 
for AQP4, 1 and 9 cDNAs respectively 298, 372 and 364 
bp from ail the three Macaca fascicu/aris brains (Fig. 1 ). 
Large amounts of AQP1 and 4 cDNA were detected, 
1000bp 
800bp 
600bp 
400bp~ 
200bp 
AQP4 
298bp 
AQP1 
372bp 
AQP9 
364bp 
Fig. 1. Real lime PCR analysis of fixed Macaca fascicularis brain 
tissue. Fragments of expected sizes for AQP4, 1 and 9 respectively 
298, 372 and 364 bp were obtained. A large amount of AQP1 and 4 
mRNA is detected, whereas we observe a weak, but specific signal for 
AQP9 mRNA. 
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AAQP4 
1cm 
Fig. 2. AQP4-immunoreactivity in a Macaca fascicu/aris coronal section at anterior commissure (AC) -5 mm. (A) lmmunolabeling of AQP4 is 
observed in grey malter (asterix). in the anterior thalamic nuclear group (Aîh), in the ventral (Vîh) and media! (Meîh) thalamic nuclear group, in the 
substantia nigra (SN), in the putamen (Pu), in the interthalamic adhesion (itha), in the globus pallidus (GP). in the !ail (TCd) and body (BCd) of the 
caudale nucleus, in the granule cell layer of the dentale gyrus (DG), in the glia limitans, in the pia mater (single lined arrow) and in the posterior column 
of fornix (pcfx). 3V, third ventricle; Ath, anterior thalamic nuclear group; BLV, body of lateral ventricle; CA 1, CA2 and CA3, Cornu Ammonis fields; ccr, 
cerebral crus; Cl, claustrum; DLG, dorsal nucleus of lateral geniculate body; ec, external capsule; exc, extreme capsule; ic, internai capsule; lns, 
lnsula; itha, interthalamic adhesion; LH, lateral hypothalamic area; MN, mammillary nuclei; opt, optic tract; PPHG, posterior parahippocampal gyrus; 
RI, reticular thalamic nuclei; si, stria terminalis; Sub, subiculum; eml, external medullary lamina. Higher magnification of several zones of Fig. 2A 
(indicated by open boxes A, B, C) and comparison of AQP4 immunolabeling in grey (GM) and white malter (WM). (B) ln grey malter, AQP4 staining 
polarizes to the astrocytic perivascular endfeet (arrows). (C) ln white malter, AQP4 staining also polarizes to the astrocytic perivascular endfeet 
(arrows). Fewer vessels are present in white malter compared Io grey malter. (D) Higher magnification of the indicated zone in Fig. 2A shows 
AQP4-immunoreactivity (IR) in the granule cell layer (GL) of the dentale gyrus in the hippocampus. AQP4 staining in the granule cell layer labels also 
perivascular astrocytic endfeet (arrows). PL, polymorphie layer; GL, granule cell layer; ML, molecular cell layer; vx, vessels. Bar=1 cm in (A); bar=25 
µm in (B. C, D). 
whereas a weak, but specific signal was obtained for 
AQP9 cDNA (Fig. 1) demonstrating the presence of AQP9 
mRNA in Macaca fascicularis brain on adjacent slices 
used for immunolabeling (see below). 
AQP4 immunolabeling in astrocytic perivascular 
endfeet 
AQP4 labeling was systematically studied in ail structures 
of the fixed Macaca fascicu/aris brain. Low magnification 
(Fig. 2A) showed that AQP4 staining was present in grey 
matter (GM), in several brain areas such as the anterior 
thalamic nuclear group (A Th), the ventral (VTh) and medial 
(Me Th) thalamic nuclear group, the substantia nigra (SN), 
the putamen (Pu), the globus pallidus (GP), the tail (TCd) 
and body (BCd) of the caudate nucleus and the granule 
cell layer of the dentate gyrus (DG). High AQP4 staining 
was also observed in the glia limitans, pia mater and the 
posterior column of fornix (pcfx). The wide distribution of 
AQP4 staining is in accordance with the intense band 
observed in RT-PCR experiments (Fig. 1). 
Higher magnification of grey and white matter (Fig. 28, 
C) revealed, as in rodents, that AQP4 staining is polarized 
in the astrocytic perivascular endfeet along blood vessels. 
A higher vascular density in the grey matter compared to the 
white matter might explain why AQP4-immunoreactivity 
(AQP4-IR) was stronger in the grey matter (Fig. 2A). ln the 
dentate gyrus of the hippocampus, AQP4 staining was ob-
served in astrocyte processes in contact with blood vessels 
and also in astrocyte processes localized in between neuro-
nal cell bodies (Fig. 20). AQP4 expression and distribution 
are comparable between rodent and primate brains, suggest-
ing a conserved functional role in evolution. 
AQP1 distribution in Macaca fascicularls brain 
AQP1 labeling was systematically studied in ail structures 
of fixed Macaca fascicu/aris brain. ln accordance with pre-
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Fig. 3. Double immunohistochemistry with anti-GFAP (green, ar-
rows) , anti-AQP1 (red, arrowheads) antibodies and DAPI nucleus 
staining (blue) . This experiment reveals the speci ficity of the anti-
AQP1 antibody for epithelia l cells of choroid plexus in accordance with 
previous publications. Bar= 25 µm. For interpretalion of the references 
to color in this figure legend, the reader is referred to the Web version 
of this article. 
vious studies performed in rodent brains (de Castro Ri-
beiro et al ., 2006; Gomori et al ., 2006), immunolabeling 
with anti-AQP1 antibodies was observed in the choroid 
plexus epithelial cells (Fig. 3), showing that the commercial 
APQ1 antibody specifically recognized the AQP1 epitope 
in primate brains. 
AQP1 immunolabeling (Fig. 4A) was not only restricted 
to the choroid plexus, but was also detected in white matter 
tracts , including the subcortical white matter, the internai 
(ic), external (ec) and extreme (exc) capsule and in the 
cerebral crus (ccr) (Fig. 4A). AQP1 staining was also ob-
served around the optic tract (opt), in the tail (TCd) and 
body (BCd) of the caudate nucleus, in the lateral medullary 
lamina which separates the putamen (Pu) from the globus 
pallidus (GP), in the hippocampus Cornu Ammonis fields 
CA1 to CA3 and in the granule cell layer of DG (Fig. 4A) . 
lt is interesting to note that AQP1 immunoreactivity does 
not overlap with AQP4 staining (Figs. 2A and 4A) in sev-
eral regions (white and grey matter, medial (MeTh) and 
ventral (VTh) thalamic nuclear group, substantia nigra 
(SN), putamen (Pu), cerebral crus (ccr)) . 
Observations at higher magnification of the outlined 
regions shown in Fig. 4A revealed that AQP1-IR in grey 
and white matter was bath due to an astrocyte-like label-
ing, with staining on cellular processes and perivascular 
endfeet (Fig. 48, C). Higher magnification of the hippocam-
pus (Fig. 4D) revealed a strong AQP1 -immunolabeled 
granule cell layer of the DG with immunolabeled cell bod-
ies and processes reaching from the granule cell layer into 
the molecular layer of the DG. 
Double immunofluorescence with anti-glial fibrillary 
acidic protein (GFAP) and anti-AQP1 antibodies showed 
co-localization of these markers in the perivascular astro-
cytes suggesting that AQP1 is expressed in astrocytes 
(Fig. 5A-C) . Astrocytic AQP1 immunoreactivity could also 
be seen in the glia limitans (Fig. 5A-C) . ln the white matter 
(Fig. 4C), we also note immunoreactivity in stellate cell 
bodies, suggesting expression in astrocytes. These la-
beled astrocytic soma contribute to the strong labeling in 
white matter (Fig. 4A, C). Comparison of GFAP and AQP1 
staining in Fig. 5A shows that not all GFAP positive cells 
were labeled AQP1 . This result is in contras! to AQP4-IR 
which is observed in all GFAP stained astrocytes (data not 
shown). Here, we provide evidence that AQP1 may be a 
marker of a distinctive subpopulation of astrocytes present 
in the white matter of the primate brain. 
Higher magnification of the emerging oculomotor nerve 
(Fig. 5D, E) revealed GFAP-AQP1-IR between the nerve 
fibers; a space filled by Schwann cells and endoneurium. 
Bath nerve fibers and Schwann cells are enveloped by 
endoneurium, a loose connective tissue rich in vasa ner-
vorum. Previous studies showed GFAP-labeling around 
nerve fibers in Schwann cells (Jessen and Mirsky, 1984; 
Jessen et al. , 1990). Thus, AQP1 and GFAP co-localiza-
tion in Schwann cells (Fig. 5D, E) could indicate a raie in 
axon to Schwann cell signaling (Jessen et al ., 1990), im-
portant for the maintenance of the nerve fiber microenvi-
ronment and its physiological functioning . 
lnterestingly, AQP1 staining without GFAP labeling 
was present on pial blood vessels (Fig. 5D, F). We noted 
AQP1-IR depicting soma as well as prolongations (Fig. 
5F) . Double immunolabeling with anti-Neurofilament (NF) 
antibodies clearly showed that AQP1 labeling is located in 
neuronal soma (Fig. 6) and their bipolar processes running 
around the blood vessels (Figs. 5F and 6). AQP1 labeling 
in these processes surrounded the NF staining, suggesting 
that AQP1 was inserted in the cell membrane of these 
neurons which innervate the pial blood vessels (Fig. 6). 
AQP9 immunolabeling in catecholaminergic neurons, 
in cortical isolated neurons and in astrocytes 
AQP9 immunolabeling was systematically studied in all 
structures of fixed Macaca fascicu/aris brain. Regional ob-
servations (Fig. 7 A) revealed AQP9 immunoreactivity pre-
dominantly in the grey matter, the medial (MeTh) and 
ventral (VTh) thalamic nuclear group, the lateral geniculate 
body (DLG), the substantia nigra (SN), the !ail (TCd) and 
body (BCd) of the caudale nucleus, the Cornu Ammonis 
fields CA 1 to CA3, the granule cell layer of the DG and the 
subiculum (Sub) of the hippocampus. 
ln the insula cortex (Fig. 78), the precentral gyrus (Fig. 
7C) and other brain areas, AQP9 staining was located in 
the astrocytic cell bodies and processes running towards 
vessels and in their perivascular endfeet. This AQP9 lo-
calization is in agreement with previous publications in 
rodent brains (Badaut et al. , 2001 , 2004), and double 
immunolabeling with GFAP shows co-localization of bath 
markers (data not shown). 
AQP9 immunoreactivity was also observed in several 
neurons (Figs. 7D and 8), indicating TH-positive neurons 
located in the> substantia nigra (Fig. 8), in agreement with 
observations in rodent brains (Badaut et al ., 2004; de 
Castro Ribeiro et al., 2006) where AQP9 expression was 
seen in catecholaminergic neurons. ln these neurons, 
AQP9 labeling was observed in the cell membrane as well 
as in the cytoplasm (Fig. 8). ln primates, additional AQP9 
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Fig. 4. AQP1-immunoreactivity in a Macaca fascicularis coronal section at -5 mm. {A) lmmunolabeling is found in the choroid plexus {double 
lined arrow), in white malter (asterix) such as in the extreme (exc), external (ec) and internai capsule (ic), in the cerebral crus (ccr) which is the 
anterior part of the cerebral peduncle containing corticospinal, corticopontine and corticobulbar motor tracts, around the optic tract (opt) and the 
stria terminalis (st.) , as well as in the lateral medullary lamina (arrow heads) , separating the putamen (Pu) from the globus pallidus (GP) and 
in the external medullary lamina (eml), separating the ventral thalamic nuclear group (VTh) from the thalamic reticular nucleus (RI). Other 
structures like the glia limitans (pentagonal arrows) , and pia mater (single lined arrows) surrounding the glia limitans , are labeled. lmmunore-
activity is also revealed around the tail (TCd) and body (BCd) of the caudale nucleus, in the interthalamic adhesion (itha) , in the field H, 
separating the ventral thalamic nuclear group (VTh) from the substantia nigra (SN) , in Cornu Ammonis fields CA 1, CA2 and CA3 and in the 
granular and molecular cell layers of the dentale gyrus (DG) of the hippocampus. lmmunoreactivity is also strong in the posterior column of fornix 
(pcfx). 3V, third ventricle; ATh, anterior thalamic nuclear group ; BLV, body of lateral ventricle; Cl , claustrum ; DLG, dorsal nucleus of lateral 
geniculate body; lns, lnsula ; Meîh, media! thalamic nuclear group; MN, mammillary nuclei; PPHG, posterior parahippocampal gyrus; Sub, 
subiculum. (B) A higher magnificaticn of the grey malter (GM) reveals a few vessels (vx) surrounded by immunolabeled perivascular endfeet 
(arrows) as well as their immunolabeled prolongations (arrow heads) , suggesting the presence of astrocytes. (C) As seen in the coron al section , 
AQP1 staining is stronger in white malter (WM) than in grey malter (GM) . ln contras! Io grey malter (GM), in white malter (WM) we also observe 
immunoreactivity in stellate cell bodies (double lined arrows), suggesting AQP1 expression in astrocytic cell bodies. These cell bodies show 
immunolabeled perivascular endfeet (single lined arrows) and immunolabeled prolongations (arrow heads). (D) AQP1 -immunoreactivity in the 
hippocampus of Macaca fascicularis brain . The hippocampus region reveals a strongly immunolabeled granule cell layer (GL) . Higher 
magnification allows identification of immunolabeled cell bodies (open arrow heads) in the granule cell layer of the dentale gyrus and 
immunolabeled processes (closed arrow heads) reaching from granule cell layer to the molecular layer (ML) of the DG. Single lined arrows show 
the staining in perivascular end feet, suggesting the presence of astrocytes. PL, polymorphie layer; GL, granule cell layer; ML, molecular cell 
layer. Bar= 1 cm in (A); bar = 25 µm in (B-D). 
positive neurons were also observed in the insula cortex as 
well as in other brain areas such as the fourth layer of the 
precentral gyrus (primary motor cortex) (Fig. 7D). AQP9-
labeled neurons exhibiting an oval shape were found lo-
cated in the cortical layer IV (Fig. 7D). lnterestingly, 
AQP9-IR was observed in the DG (Fig. 7A, E, F). Higher 
magnification revealed a strongly immunolabeled granule 
cell layer of the DG, with immunolabeled cell bodies and 
processes reaching from the granule cell layer into the 
molecular layer (Fig. 7E, F). Cell bodies were stained with 
AQP9 in the granular layer as well as in the polymorphie 
layer (Fig. 7F). 
DISCUSSION 
lnterest in AQP expression in human pathologies is ori-
ented towards the development of new drugs to prevent 
edema formation . Recently, the relevance to study AQP4 
in human diseases has been strengthened by the discov-
ery of the AOP4 antibody in blood of patient suffering of 
neuromyelitis optica (NMO), and is now a biomarker of this 
neurodegenerative disease (Lennon et al. , 2005; Weinsh-
enker et al., 2006). However, most AQP studies have 
been carried out in the rodent brain (Badaut et al. , 2007, 
2002; Ta it et al ., 2008 ; Verkman et al ., 2006), but a small 
r 
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Fig. 5. (A-C) AQP1 (red)-GFAP (green) double immunofluorescence in the glia limitans. Large arrow heads indicate the co-localization (yellow) in the glia limitans. 
Single lined arrows point out an astrocyte with ils double immunolabeled prolongations. We also observe astrocytic prolongations that are GFAP positive, but AQP1 
negative (double lined arrows in Fig. 5A-C). (D) AQP1 staining in red, GFAP labeling in green and DAPI in blue. Double immunolabeling reveals AQP1 and GFAP 
immunoreactivities in the cerebral crus, a strongly GFAP stained oculomotor nerve and a predominant AQP1 immunoreactive pia mater, containing vascular 
structures (double lined arrows). (E) Higher magnification, of the zone indicated by an open box in Fig. SD, allows the identification of GFAP (green)-AQP1 (red) 
positive Schwann cells (hexagonal-arrows) in the endoneurial space around the nerve fibers of oculomotor nerve axons (asterixes). (F) A closer look into the pia 
mater surrounding the emerging oculomotor nerve, reveals AQP1 immunolabeling of fibers (double lined arrows) and œll bodies (arrows) interconnected by the 
stained fibers, suggesting a neuronal formation which runs along a blood vessel. There is no detectable GFAP staining in the pia mater. Bar=25 µm in (B-0, F); 
bar=0.25 mm. For interpretation of the references to color in this figure legend, the reader is referred Io the Web version of this article. 
number of reports have been published using human 
brain tissue samples, showing regulation of AQP ex-
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Fig . 6. AQP1 -labeling (red) and neurofilament (NF, green) staining are 
colocalized on a pial vessel. Neuronal cell bodies on the pial vessel 
are AQP1 -immunolabeled (arrow heads) and their NF-positive ax-
ons are surrounded by AQP1 immunolabeling (double lined arrows). 
Bar=25 µm. For interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of this article . 
pression in pathological conditions. Human brain tissues 
were obtained after surgery (Badaut et al. , 2003; Fatemi 
et al. , 2008a ; Saadoun et al. , 2002a ,b; Satoh et al ., 
2007; Suzuki et al., 2006) or autopsy (Satoh et al ., 
2007). To date, little is known about the distribution and 
expression of AQPs in normal primate brains. Here we 
report for the first time, the expression and cell localiza-
tion of the three most studied AQPs in the rodent brain, 
AQP1 , 4 and 9, in the Macaca fascicularis brain. We 
show that while the major rodent expression pattern is 
conserved for AQP4, there are some differences be-
tween rodents and non-human primates for AQP1 and 9. 
This knowledge is highly relevant for future development 
and testing of new drugs aimed to directly modify the 
permeability properties of AQPs to prevent edema for-
mation in brain diseases. 
AQP4 distribution 
Similarly to previous description in rodent brains, AQP4 
protein was found in perivascular astrocytic endfeet, and in 
contrast to AQP1, mainly in grey matter, but also in the glia 
limitans and pia mater. As previously described (Badaut et 
al ., 2000b), we also noted high AQP4 expression in the 
1110 1. 1. Arciénega et al./ Neuroscience 167 (2010) 1103-1114 
AQP9 
Fig. 7. AQP9 immunoreactivity in a coronal Macaca fascicularis brain section at - 6 mm. (A) Staining is revealed in grey malter (asterix), in the 
lnsula cortex (lns), in the ventral {VTh), medial (Me Th) and reticular (Rt) thalamic nuclei , in the tail (TCd) and body (BCd) of the caudale nucleus, 
in the glia limitans (pentagonal arrows) , in the pia mater (single lined arrows) , in the substantia nigra compacta (SNc) and reticulata (SNr), in 
Cornu Ammonis fields CA 1, CA2, CA3, in the dentale gyrus (DG) and in the subiculum (Sub) of the hippocampus. Compared to AQP1 labeling 
(Fig . 4) where the staining is mostly found in white malter and around the basal ganglia, AQP9 labeling is observed in the cortex and the basal 
ganglia system (except for the putamen and globus pallidus). The indicated squares are shown in higher magnification in the corresponding 
figures . 3n, oculomotor nerve; 3V, third ventricle; bec, body of corpus callosum; BLV, body of lateral ventricle; ccr, cerebral crus; Cl, claustrum; 
DLG, dorsal nucleus of lateral geniculate body; ec, external capsule; exc, extreme capsule; GP, globus pallidus; lns, lnsula; ipf, interpeduncular 
tossa; itha, interthalamic adhesion; lml, lateral medullary lamina; Me Th, medial thalamic nuclear group; pcfx, posterior column of fornix; Pu, 
putamen; PPHG, posterior parahippocampal gyrus ; Sub, subiculum; VTA, ventral tegmental area. (B-D) Magnification of the cortical region of 
the precentral gyrus (PrG) as indicated in Fig. 7A, reveals expression of AQP9 in perivascular astrocytic endfeet (Fig . 7B, C, arrows) and in 
astrocytic cell bodies (Fig. 7B, double lined arrow) as well as in oval shaped cell bodies of 10 to 15 µm of diameter (Fig. 70 , arrow heads). (E, 
F) The hippocampus region reveals high AQP9-IR in the granule cell layer. Higher magnification allows identification of immunolabeled cell 
bodies (open arrow heads) and processes (arrows) in the granule cell layer of the dentale gyrus. ln Fig . 7F, higher magnification shows the cell 
bodies in the granule cell layer of small cells (open arrow heads) and bigger cells (arrow) , suggesting the presence of two populations of cells . 
Bar= 1 cm in (A) ; Bar= 1 OO µ.m in (E); bar= 25 µm in (B-D, F). 
granule cell layer of the DG (Fig. 20), limited to astrocytic 
endfeet. Generally, AQP4 labeling in primate brains is 
limited to astrocytic perivascular endfeet. ln accordance to 
numerous previous reports in rodent brains (Badaut et 
al., 2007; Tait et al., 2008), we suggest that this specific 
AQP4 localization, in close contact to the cerebral blood 
vessels, as well as at the interface of the cerebrospinal 
fluid (CSF)-brain barrier, shows an important raie in 
brain water homeostasis and in the formation and reab-
sorption of brain edema. Our results highlight that brain 
AQP4 distribution is highly conserved between species 
from chicken (Goren et al ., 2006; Saito et al., 2005) to 
primates (Fig. 2); suggesting that perivascular AQP4 
plays a key raie in brain water homeostasis in ail spe-
cies. AQP4 was also observed in the granule cell layer in 
the dentale gyrus of the hippocampus where we also 
noted expression of AQP1 and AQP9. Their potential 
raies will be discussed below. 
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Fig. 8. (A, B) AQP9 immunolabeling in the substantia nigra compacta with positive cell bodies (arrows) in (A) and (B) (al higher magnification). 
Neuronal processes were also stained with AQP9 (8). (C-E) TH (red) and AQP9 (green)-double immunofluorescent stain ing of substantia nigra (Fig. 
SE) reveals an AQP9-staining of cell bodies (Fig . SC, arrow) with the same morphology as TH positive neurons (Fig. BD, arrow) , showing AQP9 
expression in catecholaminergic neurons. We note bath cytoplasmic and membrane expression of AQP9 (Fig. SC, arrow), whereas TH is only 
expressed in the membrane of catecholaminergic neurons (Fig . BD, arrow). Bar= 50 µ.m in (A); Bar = 25 µ. m in (B-E). For interpretation of the 
references to color in this figure legend, the reader is referred to the Web version of this article. 
AQP1 distribution and its potential roles 
As previously proposed for rodent brains (Nielsen et al., 
1993; Oshio et al ., 2005), AQP1 may contribute to cere-
brospinal fluid formation in Macaca fascicu/aris brains. 
Whole brain analysis of AQP1 expression showed three 
additional locations in Macaca fascicu/aris: (1) in astro-
cytes, with a preference for white malter astrocytes (Fig. 
4A) ; (2) in Schwann cells surrounding the oculomotor (Fig. 
50 , E) and trigeminal (data not shown) cranial nerve fibers; 
and (3) in neurons on the surface of the pial blood vessels 
(Fig. 68). 
For the first lime in Macaca fascicularis brain , we report 
AQP1 expression in astrocytic soma in white malter and 
the glia limitans as well as in their prolongations and vas-
cular endfeet. ln contras! to AQP4, only approximately one 
out of four GFAP-positive astrocytes were labeled by anti-
AQP1 . AQP1 was preferentially expressed in astrocytes of 
the white malter, suggesting that AQP1 may be a marker 
of a sub-population of astrocytes. ln grey malter, the most 
abundant type of astrocyte is the protoplasmic astrocyte. 
Human protoplasmic astrocytes have numerous pro-
cesses and a 27-fold greater volume !han protoplasmic 
astrocytes found in redents (Oberheim et al ., 2006). Fi-
brous astrocytes show less ramifications !han protoplas-
mic astrocytes and have fewer GFAP-positive processes 
which , in contras! to protoplasmic processes, intermingle 
and do not respect a domain structure (Oberheim et al ., 
2006). ln accordance with findings in human brain tissue 
(Satoh et al., 2007), our results in Macaca fascicularis 
brain suggest that AQP1 is a marker of fibrous astrocytes 
which seem to exhibit highly branched processes (Fig. 
5C). AQP1 may play a complementary role to AQP4 in 
astrocytes i:i the regulation of brain water homeostasis in 
primates. 
Recently, expression of AQP1 in reactive astrocytes 
was shown in human brain pathologies, such as Alzhei-
mer's disease, multiple sclerosis, ischemic brain lesions, 
brain edema and epilepsy (Badaut et al ., 2003; Misawa et 
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al., 2008; Satoh et al., 2007). Sorne studies have also 
shown an intracellular location for AQP1 in astrocytes 
(Dohke and Turner, 2002; Marinelli et al., 1997). ln patho-
logical conditions, AQP1 is proposed to play a role in brain 
water movement (Badaut et al., 2003; Satoh et al., 2007; 
Suzuki et al., 2006). However, AQP1 as well as AQP4 
were recently shown to be involved in cell growth and 
migration (Saadoun et al., 2005a,b) and therefore, AQP1 
in collaboration with AQP4 may play a role in glial scar 
formation by facilitating cell migration in pathological con-
ditions. ln normal primate brains, the presence of AQP1 in 
a single population of astrocytes suggests that this subtype 
may be dedicated to the rapid mobilization of cells after 
brain injury. This population of astrocytes with highly ram-
ified processes is a population which detects modifications 
in the environment by rapid formation of filopodia. ln patho-
logical states, these AQP1 positive astrocytes could be 
more rapidly recruited to form reactive astrocytes. This 
hypothesis is coherent with observations of AQP1 in reac-
tive astrocytes in several diseases (Badaut et al., 2003; 
Satoh et al., 2007; Suzuki et al., 2006). 
Additional glial locations were also shown in peripheral 
nerves with GFAP-AQP1 co-expression in Schwann cells 
which envelop the oculomotor (Fig. 5D, E) and trigeminal 
(not shown) nerve fibers. The presence of AQP1 was 
previously reported in distant Schwann cells and also in 
human peripheral nerves (such as pancreatic and sciatic 
nerve bundles) (Gao et al., 2006; Nandasena et al., 2007). 
AQP4 expression was not observed in oculomotor or tri-
geminal nerve axons, suggesting that AQP1 ls a marker of 
Schwann cells which myelinate nerve axons in the periph-
eral nervous system. As suggested above, AQP1 may be 
involved in water homeostasis in myelinated axons during 
electrical activity. However, more functional experiments 
will be necessary to determine the exact function of this 
channel in peripheral nerves. 
AQP1 was also reported in primary sensory neurons in 
rodents and proposed to play a role in nociception, such as 
thermal and chemical pain reception (Oshio et al., 2006; 
Shields et al., 2007). ln addition to these locations in rodent 
brains, we report for the first time that AQP1 is expressed 
in neuronal cell bodies and axons on pial vessels in mon-
keys (Flgs. 5D, F and 6). Recent experiments in rodents 
showed that AQP1 ls expressed in sensory neurons ex-
pressing substance P {Shields et al., 2007). lt is well 
known that the pial blood vessels are innervated by pep-
tiderglc (substance P) and nitrergic neurons coming from 
different ganglia, such as the trlgeminal and sphenopalatin 
ganglia respectively (ladecola et al., 1994; Yamamoto et 
al., 1983). Taken together, we suggest that AQP1 protein 
is found in peptidergic and nitrergic neurons runnlng on 
pial blood vessels. Recently, AQP1 was shown to facilitate 
the diffusion of nitric oxide (NO) and to contribute to va-
sorelaxation (Herrera and Garvin, 2007; Herrera et al., 
2006), raising the hypothesis that neuronal AQP1 may 
contribute to NO diffusion from neurons to smooth muscle 
cells of pial blood vessels. 
ln summary, the biggest differences between rodents 
and non-human primates were observed for AQP1 distri-
bution with new cell locations such as astrocytes, Schwann 
cells and pial blood vessel innervations. 
AQP9 distribution and its potential roles 
AQP9 ls an aquaglyceroporin, whlch means Il is also per-
meable to glycerol, urea and monocarboxylates, such as 
lactate. We have suggested a role for AQP9 in brain en-
ergy homeostasis (Badaut et al., 2007) and have de-
scribed ils expression in astrocytes and catecholaminergic 
neurons (Badaut and Regli, 2004). The level of expression 
in the brain as well as in the liver is regulated by plasma 
insulin concentrations, arguing for a role of AQP9 in energy 
metabolism (Badaut et al., 2008). However, immunocyto-
chemical analyses have provided divergent results con-
cerning the expression of AQP9 in brain. Ils presence in 
mice brain was questioned (Rojek et al., 2007) but was 
also confirmed in rat and mouse tyrosine hydroxylase-
positive neurons, in hilar and pyramidal cells of hippocam-
pus as well as in numerous cell populations in the neocor-
tex (Mylonakou et al., 2009). Mylonakou et al. (2009) stud-
ied several antibodies used in the various studies and 
concluded that the inconsistency between the immnocyto-
chemical studies reflects differences between the specific-
ity of antibodies used. They conclude that the AQP9 rabbi! 
polyclonal antibody from Alpha Diagnostics produces the 
most reliable results (Mylonakou et al., 2009) and as with 
their studies, this study has been conducted with AQP9 
rabbi! polyclonal antibody from Alpha Diagnostics. 
We demonstrate the presence of AQP9 mRNA in pri-
mate slices adjacent to those used in immunohistochem-
istry. The results are in agreement with previous studies in 
rodent brains (Badaut et al., 2004; Mylonakou et al., 2009), 
where we observe AQP9 protein in astrocyte cell bodies, 
processes and endfeet in grey malter (Fig. 7C, D) and in 
catecholaminergic neurons (Fig. 8). Here, we provide ar-
guments for the expression of AQP9 in the non-human 
primate brain. However, the exact role of this aquaglycero-
porin is still hypothetical and needs further investigation. 
The presence of AQP9 was also observed in a second 
population of neurons in monkey brains with an oval shape 
in layer IV of the precentral gyrus (Fig. 7A) and the DG 
area of the hippocampus. This distribution is in accordance 
with the pattern of AQP9 mRNA distribution in mouse 
brains (Mylonakou et al., 2009). The functional raie of 
AQP9 in these cells needs to be studied further. 
lnterestingly, the pattern of AQP9, AQP4 and AQP1 
staining in the DG is similar to the staining observed in the 
sub-ventricular zone in rodent brains (Cavazzin et al., 
2006). The latter location is known to be a niche for adult 
progenitor cells (Cavazzin et al., 2006) as well as the DG 
of the hippocampus (Gage, 1998; Palmer et al., 1997; 
Song et al., 2002). The presence of AQP9, AQP4 and 
AQP1 in these ragions suggests expression in progenitor 
cells. ln agreement, previous studies have reported the 
presence of AQP9 and AQP4 in murine neural stem cells 
(NSC) (Cavazzin et al., 2006; La Porta et al., 2006). High 
expression of these AQPs (AQP1, AQP4, AQP9) in neural 
cell progenitor niches may be related to the high prolifer-
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ation rate in this brain area requiring fine tuning of bath 
water and energy homeostasis. 
CONCLUSION 
ln conclusion, the present study is the first to demonstrate 
the presence of the three major AQPs in Macaca fascicu-
/aris brains. AQP4 is the major aquaporin, expressed ex-
clusively in astrocytes with a preferential location in 
perivascular astrocyte endfeet. We show an interesting 
distribution of AQP1 in a sub-population of astrocytes. lts 
raie in these cells is not yet determined and needs further 
investigation. Our work suggests that results obtained in 
previous studies in pathological rodent models such as 
brain ischemia with AQPs cannot automatically be trans-
posed to human clinical studies. We suggest that AQP4 is 
not involved alone in brain water homeostasis, but that 
AQP1 may also be part of the regulation process. AQP9 
mRNA and proteins are present in primate brain, with 
additional locations in the cortex and hippocampus. Fur-
ther investigation in brains with models of non-human pri-
mate pathologies will be extremely useful to determine 
possible raies of each AQP in edema and other pathophys-
iological mechanisms. 
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